The Investigational Multi-Targeted Kinase Inhibitor TAK-901 Antagonizes Acute Myeloid Leukemia Pathogenesis: Results of Preclinical StudiesPatrick R. Griffin, Jennifer S. Carew, Takashi Satou et al.|Blood|2011Cited by 1